If production costs fall to ~1,500 per month, we can build the margin stack: Ex-Factory Price: Add a manufacturer margin of 35%-40%, bringing the ex-factory price to ~2,400-2,600
This is not recommended by any medical authority and creates significant dosing uncertainty
For many, this improvement may also rebalance hormonal levels, creating a more favorable environment for conception
Read the complete paper here: #KrishgenBiosystems #KRIBIOLISA #Semaglutide #ELISA #Pharmacokinetics #Bioanalysis #TranslationalResearch #DrugDelivery #PulmonaryDelivery #LifeSciences #DrugDevelopment To view or add a comment, sign in As RNAi therapeutics advance toward broader indications and commercial-scale production, developers reach a critical inflection point: scaling efficiently without compromising control
Seeing you in front- Jacquelyn Cobb: Just because I look like- Paul Goldberg: of the halo
For a lot of women, that change is the difference between spinning their wheels and finally seeing steady movement